172 related articles for article (PubMed ID: 21165571)
1. Association of the transforming growth factor ß1 promoter polymorphism, C-509T, with smoking status and survival in advanced non-small cell lung cancer.
Togashi Y; Masago K; Fujita S; Kim YH; Sakamori Y; Hatachi Y; Fukuhara A; Nagai H; Mio T; Mishima M
Oncol Rep; 2011 Feb; 25(2):377-82. PubMed ID: 21165571
[TBL] [Abstract][Full Text] [Related]
2. Association between single nucleotide polymorphisms of the transforming growth factor-β1 gene and overall survival in unresectable locally advanced non-small-cell lung cancer patients treated with radio(chemo)therapy in a Chinese population.
Xue SL; Zheng YH; Su HF; Deng X; Zhang XB; Zou CL; Hu ML; Xie CY
Med Oncol; 2013 Jun; 30(2):512. PubMed ID: 23435990
[TBL] [Abstract][Full Text] [Related]
3. Association between TGF-β1 rs1982073/rs1800469 polymorphism and lung cancer susceptibility: An updated meta-analysis involving 7698 cases and controls.
Chen G; Hu C; Lai P; Song Y; Xiu M; Zhang H; Zhang Y; Huang P
Medicine (Baltimore); 2019 Nov; 98(47):e18028. PubMed ID: 31764821
[TBL] [Abstract][Full Text] [Related]
4. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy.
Lim CS; Kim YS; Chae DW; Ahn C; Han JS; Kim S; Lee JS; Kim IS
Clin Nephrol; 2005 Feb; 63(2):61-7. PubMed ID: 15730046
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β1 29T>C genetic polymorphism is associated with lymph node metastasis in patients with adenocarcinoma of the lung.
Minamiya Y; Miura M; Hinai Y; Saito H; Ito M; Ono T; Toda H; Motoyama S; Ogawa J
Tumour Biol; 2010 Oct; 31(5):437-41. PubMed ID: 20506050
[TBL] [Abstract][Full Text] [Related]
6. TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy.
Yuan X; Wei Q; Komaki R; Liu Z; Yang J; Tucker SL; Xu T; Heymach JV; Lu C; Cox JD; Liao Z
PLoS One; 2013; 8(6):e65659. PubMed ID: 23840350
[TBL] [Abstract][Full Text] [Related]
7. A functional polymorphism C-509T in TGFβ-1 promoter contributes to susceptibility and prognosis of lone atrial fibrillation in Chinese population.
Cao H; Zhou Q; Lan R; Røe OD; Chen X; Chen Y; Wang D
PLoS One; 2014; 9(11):e112912. PubMed ID: 25402477
[TBL] [Abstract][Full Text] [Related]
8. Identification and association of the single nucleotide polymorphisms, C-509T, C+466T and T+869C, of the TGF-β1 gene in patients with asthma and their influence on the mRNA expression level of TGF-β1.
Panek M; Pietras T; Fabijan A; Zioło J; Wieteska L; Małachowska B; Fendler W; Szemraj J; Kuna P
Int J Mol Med; 2014 Oct; 34(4):975-86. PubMed ID: 25119113
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of transforming growth factor-β1 associated with increased risk of gastric cardia adenocarcinoma in north China.
Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G; Shan B
Int J Immunogenet; 2011 Jun; 38(3):215-24. PubMed ID: 21205231
[TBL] [Abstract][Full Text] [Related]
10. CC genotype of anti-apoptotic gene BCL-2 (-938 C/A) is an independent prognostic marker of unfavorable clinical outcome in patients with non-small-cell lung cancer.
Javid J; Mir R; Mirza M; Imtiyaz A; Prasant Y; Mariyam Z; Julka PK; Mohan A; Lone M; Ray PC; Saxena A
Clin Transl Oncol; 2015 Apr; 17(4):289-95. PubMed ID: 25257838
[TBL] [Abstract][Full Text] [Related]
11. SNPs in the TGF-β signaling pathway are associated with increased risk of brain metastasis in patients with non-small-cell lung cancer.
Li Q; Wu H; Chen B; Hu G; Huang L; Qin K; Chen Y; Yuan X; Liao Z
PLoS One; 2012; 7(12):e51713. PubMed ID: 23284751
[TBL] [Abstract][Full Text] [Related]
12. The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.
Wang S; Wang J; Bai Y; Wang Q; Liu L; Zhang K; Hong X; Deng Q; Zhang X; He M; Wu T; Xu P; Guo H
Cancer Med; 2016 Sep; 5(9):2332-42. PubMed ID: 27465648
[TBL] [Abstract][Full Text] [Related]
13. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
14. Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer.
Guerra JL; Gomez D; Wei Q; Liu Z; Wang LE; Yuan X; Zhuang Y; Komaki R; Liao Z
Radiother Oncol; 2012 Dec; 105(3):299-304. PubMed ID: 23022171
[TBL] [Abstract][Full Text] [Related]
15. Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.
Masago K; Fujita S; Kim YH; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Ichikawa M; Mio T; Mishima M
Cancer Sci; 2009 Oct; 100(10):1917-22. PubMed ID: 19594543
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.
Yuan X; Liao Z; Liu Z; Wang LE; Tucker SL; Mao L; Wang XS; Martel M; Komaki R; Cox JD; Milas L; Wei Q
J Clin Oncol; 2009 Jul; 27(20):3370-8. PubMed ID: 19380441
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.
Song B; Liu Y; Liu J; Song X; Wang Z; Wang M; Zhu Y; Han J
Respiration; 2011; 82(5):439-44. PubMed ID: 21832820
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.
Zhang X; Fan J; Li Y; Lin S; Shu P; Ni J; Qin S; Zhang Z
Tumour Biol; 2016 Jan; 37(1):1061-9. PubMed ID: 26269114
[TBL] [Abstract][Full Text] [Related]
20. The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer.
Jiang YH; Xu XL; Ruan HH; Xu WZ; Li D; Feng JG; Han QB; Mao WM
Med Oncol; 2014 May; 31(5):959. PubMed ID: 24722796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
